MicroSalt Plc
("MicroSalt" or the "Company")
Result of General Meeting
MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, announces the results of its General Meeting (“GM”), held earlier today.
All six resolutions put to members were duly passed, with the number of votes cast for, against and withheld as follows:
|
For |
Against |
Votes Withheld |
Total Votes Cast |
|||||||||
|
Number of Votes |
% |
Number of Votes |
% |
Number of Votes |
||||||||
|
Ordinary Resolutions |
||||||||||||
|
1. To authorise the Directors to allot Ordinary Shares for cash in relation to the Fundraise up to an aggregate nominal amount of £10,400.00. |
33,812,111 |
99.14% |
294,741 |
0.86% |
151,509 |
34,106,852 |
||||||
|
2. To authorise the Directors to allot Ordinary Shares for cash in connection with the exercise of convertible loan notes issued prior to the date of this resolution up to an aggregate nominal amount of £4,550.00. |
33,898,226 |
99.39% |
208,486 |
0.61% |
151,649 |
34,106,712 |
||||||
|
3. To authorise the Directors to allot Ordinary Shares for cash up to an aggregate nominal amount of £23,918.41 (being approximately 20% of the Enlarged Share Capital). |
33,812,617 |
99.14% |
294,235 |
0.86% |
151,509 |
34,106,852 |
||||||
|
Special Resolutions |
||||||||||||
|
4. Subject to the passing of Resolution 1, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of the Fundraising Shares. |
33,893,531 |
99.37% |
214,821 |
0.63% |
150,009 |
34,108,352 |
||||||
|
5. Subject to the passing of Resolution 2, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of Ordinary Shares allotted and issued on connection with the exercise of convertible loan notes issued prior to the date of this resolution. |
33,885,983 |
99.35% |
222,369 |
0.65% |
150,009 |
34,108,352 |
||||||
|
6. Subject to the passing of Resolution 3, to authorise the Directors to disapply pre-emption rights granted to Shareholders pursuant to the Act, in respect of the allotment and issue of Ordinary Shares up to an aggregate amount of £23,918.41 (being approximately 20% of the Enlarged Share Capital). |
33,789,376 |
99.06% |
318,976 |
0.94% |
150,009 |
34,108,352 |
||||||
Enquiries:
|
MicroSalt plc |
Via Gracechurch Group |
|
Rick Guiney (CEO) Gary Urmston, Interim CFO |
|
|
Zeus (Nominated Adviser and Broker) |
+44 (0)20 3829 5000 |
|
David Foreman / Ed Beddows (Investment Banking) Nick Searle (Head of Equity Capital Markets) |
|
|
Gracechurch Group (Financial PR) |
+44 (0)20 4582 3500 |
|
Heather Armstrong, Alexis Gore, Rebecca Scott |
About MicroSalt
MicroSalt is disrupting the global salt market with its patented, full-flavour, low-sodium salt designed for both food manufacturers and consumers. Using proprietary micron-sized particles, MicroSalt delivers the same salty taste as traditional salt with approximately 50% less sodium, offering a scalable solution to one of the world's most pressing health challenges.
Excess sodium consumption is a leading contributor to cardiovascular disease, the world's number one cause of death. The World Health Organisation has targeted a 30% reduction in global sodium intake by 2025, a shift projected to save seven million lives by 2030. The economic case is equally compelling: in the UK alone, cardiovascular disease costs £19 billion annually, and reducing average daily salt intake by just one gram could save over 4,000 lives and £288 million each year.
For more information, please visit www.microsaltinc.co or follow on X @microSaltPLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.